Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
30
NCT04696666
Tolerability and Efficacy of INSTYLAN in Subjects With Moderate to Severe Hemorrhagic Cystitis
Phase: N/A
Role: Lead Sponsor
Start: May 15, 2020
Completion: Jul 30, 2021